People often ask whether products made from non-psychoactive extracts of industrial hemp, in particular, tinctures, oils and infusions of cannabidiol (CBD) may be legally produced and sold in the US. Generally, the answer is no. Although there are some exceptions to the general rule, they are not yet enough to support a free, commercial market.
We all know that the federal government has continued to refuse to make the cannabusiness easy. No one is skipping down the path of stress-free commerce—not the growers, the product manufacturers, the dispensary owners or even the consumers; but what does this mean for taxes? The current trend toward not filing tax returns for those in the cannabis industry is both interesting and troubling.